Brachytherapy boost and cancer-specific mortality in favorable high-risk versus other high-risk prostate cancer

Purpose : Recent retrospective data suggest that brachytherapy (BT) boost may confer a cancer-specific survival benefit in radiation-managed high-risk prostate cancer. We sought to determine whether this survival benefit would extend to the recently defined favorable high-risk subgroup of prostate c...

Full description

Bibliographic Details
Main Authors: Vinayak Muralidhar, Michael Xiang, Peter F. Orio III, Neil E. Martin, Clair J. Beard, Felix Y. Feng, Karen E. Hoffman, Paul L. Nguyen
Format: Article
Language:English
Published: Termedia Publishing House 2016-02-01
Series:Journal of Contemporary Brachytherapy
Subjects:
Online Access:https://www.termedia.pl/Brachytherapy-boost-and-cancer-specific-mortality-in-favorable-high-risk-versus-other-high-risk-prostate-cancer,54,27008,1,1.html